Theses and Dissertations at Montana State University (MSU)
Permanent URI for this collectionhttps://scholarworks.montana.edu/handle/1/733
Browse
2 results
Search Results
Item The effects of RGGI on mortality outcomes(Montana State University - Bozeman, College of Agriculture, 2024) Power, Nicholas Markert; Chairperson, Graduate Committee: Justin GallagherMost debates around market-based solutions to reduce greenhouse gas emissions often focus on greenhouse gas emissions reductions and cost-effectiveness. The Regional Greenhouse Gas Initiative (RGGI) is a cap-and-trade program designed to curb greenhouse gas emissions, and was implemented in 2009 across nine states in the greater New England area. The World Health Organization (WHO) states that over 6.5 million people die from air pollution annually. Particulate Matter of 2.5 microns or less in diameter is a major component in greenhouse gas emissions and has a myriad of deleterious effects to human health. This paper explores whether the RGGI policy had an impact on mortality rates, using a difference-in-differences approach, and estimates reduction in Cardiovascular related mortalities for the age cohort 15-64. I estimate that there are approximately 12 fewer deaths per county effected by the RGGI policy from 2009- 2019.Combined with the 45 counties affected by the policy, there are an estimated 553 fewer cardiovascular related mortalities for the 15-64 age group from 2009-2019 as compared to the counties unaffected by the policy. Robustness checks are run to verify the reliability of this finding.Item Medical technology and mortality transition: the diphtheria antitoxin and childhood mortality in the United States, 1880-1910(Montana State University - Bozeman, College of Agriculture, 2023) Salimi Rad, Sadiq; Chairperson, Graduate Committee: D. Mark AndersonDiphtheria was a deadly infectious disease in the late 19th and early 20th centuries, particularly among children. In 1895, an antitoxin was developed that could effectively treat the disease. This was the first and only infectious disease in the United States at the time with a scientifically-based treatment. To gauge the impact of access to the antitoxin on child mortality, I leverage large and stable differences in physicians per capita rates across 38 U.S. cities. Physicians were the primary distributors of the antitoxin at the time. For every percentage point increase in the rate of physicians per capita prior to the antitoxin's availability, there is a corresponding one percent reduction in child mortality. These findings suggest that the introduction of the antitoxin played an important role in saving children's lives and had a significant impact on the course of medical technology and child health in the United States.